Viewing StudyNCT04796337



Ignite Creation Date: 2024-05-06 @ 3:53 PM
Last Modification Date: 2024-10-26 @ 1:59 PM
Study NCT ID: NCT04796337
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2021-02-22

Brief Title: A Long-term Follow-up Study of Sotatercept for PAH Treatment MK-7962-004A011-12
Sponsor: Acceleron Pharma Inc a wholly-owned subsidiary of Merck Co Inc Rahway NJ USA
Organization: Acceleron Pharma Inc a wholly-owned subsidiary of Merck Co Inc Rahway NJ USA

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-05-12
Start Date Type: ACTUAL
Primary Completion Date: 2027-09-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-11-30
Completion Date Type: ESTIMATED
First Submit Date: 2021-02-22
First Submit QC Date: March 11 2021
Study First Post Date: 2021-03-12
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-07
Last Update Post Date: 2024-06-21
Last Update Post Date Type: ACTUAL